Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Zoono Group Limited ( (AU:ZNO) ) is now available.
Zoono Group Limited has announced a change in the director’s interest, with Paul Hyslop acquiring 14,921,072 additional shares through participation in the company’s Rights Issue. This acquisition increases his total holdings to 119,368,572 shares, potentially strengthening his influence within the company and reflecting confidence in the company’s future prospects.
More about Zoono Group Limited
Zoono Group Limited operates in the biotechnology industry, focusing on the development and distribution of antimicrobial solutions. The company’s primary products include long-lasting antimicrobial sprays and sanitizers, targeting both consumer and industrial markets.
Average Trading Volume: 606,608
Technical Sentiment Signal: Sell
Current Market Cap: A$12.47M
For detailed information about ZNO stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money